 respons rheumatoid arthriti life tabl analysi followup eighty-six patient rheumatoid arthriti sulfasalazin year treatment end year probabl treatment advers effect first month treatment patient treatment inefficaci brief period improv clinic relaps use respons treatment continu rate year mark contrast pessimist longterm evalu second line drug